Biosimilars Market Industry Report 2024 - Rising Demand for Biosimilars as a Cost-effective Alternative has Promoted the Need for Increased In-house Development and Outsourcing Operations
08. November 2024 04:37 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution...
Biotechnology for the Non-Biotechnologist - 5 Day Online Training Course, December 2-6 2024
07. November 2024 09:39 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Biotechnology for the Non-Biotechnologist Training Course" has been added to ResearchAndMarkets.com's offering. The importance of the biotech...
CC Chemokine Receptor Type 5 Market Research Report 2024
07. November 2024 09:35 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC chemokine receptor type 5 market...
SUT (Single-Use Technology) Rocking Bioreactors Industry Research Report 2024-2030: Rising Biopharmaceutical Demand Fuels Growth, Shift to Single-Use Technologies Drives Adoption in Bioprocessing
30. Oktober 2024 09:53 ET
|
Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "SUT Rocking Bioreactors Market: Market Size, Trends, Opportunities and Forecast by Application, End-User, Product Type, Region, By Country: 2020-2030"...
IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
24. Oktober 2024 10:10 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
Denosumab (Prolia & Xgeva) by Amgen Biosimilars Pipeline Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
24. Oktober 2024 09:55 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides basic...
Biopharmaceuticals Manufacturing Consumables Testing Business Research Report 2024-2030
18. Oktober 2024 04:30 ET
|
Research and Markets
Dublin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Manufacturing Consumables Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...
Chronic Rhinosinusitis with Nasal Polyps Drug Pipeline Research 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
16. Oktober 2024 04:04 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Chronic...
Autoimmune Hepatitis Pipeline Market Research 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
16. Oktober 2024 04:03 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Hepatitis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Immunosuppressants Research Report 2023-2024 & 2030: Healthcare Focus on Targeted, Patient-Centric Treatments Spurs Multi-Billion Dollar Growth Amid Rising Organ Transplants and Autoimmune Diseases
15. Oktober 2024 09:37 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Immunosuppressants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...